Celano Michael has filed 6 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 37604 shares of Larimar Therapeutics, Inc. ($LRMR) on January 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | Larimar Therapeutics, Inc. | $LRMR | Celano Michael | Chief Financial Officer | A | Common Stock | 37604 | $0.00 | 215,785.0000 | 85,590,392 | 21.10% | 0.04% |
| Jan. 26, 2026 | Larimar Therapeutics, Inc. | $LRMR | Celano Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 225622 | $0.00 | 225,622.0000 | 85,590,392 | 9999.99% | 0.26% |
| Jan. 22, 2025 | Larimar Therapeutics, Inc. | $LRMR | Celano Michael | Chief Financial Officer | A | Common Stock | 34185 | $0.00 | 178,181.0000 | 63,815,065 | 23.74% | 0.05% |
| Jan. 22, 2025 | Larimar Therapeutics, Inc. | $LRMR | Celano Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 205111 | $0.00 | 205,111.0000 | 63,815,065 | 9999.99% | 0.32% |
| Jan. 17, 2024 | Larimar Therapeutics, Inc. | $LRMR | Celano Michael | Chief Financial Officer | A | Common Stock | 31250 | $0.00 | 143,996.0000 | 43,909,069 | 27.72% | 0.07% |
| Jan. 17, 2024 | Larimar Therapeutics, Inc. | $LRMR | Celano Michael | Chief Financial Officer | A | Stock Option (Right to Buy) | 187500 | $0.00 | 187,500.0000 | 43,909,069 | 9999.99% | 0.43% |